Compare ARK Genomic Revolution ETF (ARKG) vs iShares Russell 2000 ETF (IWM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares Russell 2000 ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares Russell 2000 ETF trades at $295.41. Which is the better fit depends on your goals.
| ARKG | IWM | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $300.45 |
52-Week Low | $23.09 | $214.95 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IWM (iShares Russell 2000 ETF) trades at $295.97, down 0.44% with a bullish technical signal from moving averages. The ETF holds nearly 2,000 small-cap stocks and has gained 22.1% year-to-date, outperforming major indices. Recent news highlights small-cap strength amid shifting rate expectations, with the Russell 2000 showing its first significant pattern since 1991 according to The Motley Fool (July 6, 2026).
Small-cap exposure offers growth potential during economic expansion but carries higher volatility risks. Current technical support sits at $295 with resistance at $299. The ETF's 26-year track record of 8.6% annualized returns supports long-term positioning, though interest rate sensitivity remains a key monitorable for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →
